| Peak Healthcare At Caton Manor | |
| 3330 Wilkens Avenue, Baltimore, Maryland 21229 | |
| (410) 525-1544 | |
| Name | Peak Healthcare At Caton Manor |
|---|---|
| Location | 3330 Wilkens Avenue, Baltimore, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 140 |
| Occupancy Rate | 53.64% |
| Medicare ID (CCN) | 215085 |
| Legal Business Name | Wilkens Ave Baltimore Md Opco Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1013615681 |
| Organization Name | GWYNNFALLS MD OPCO |
| Doing Business As | CARROLL PARK HEALTHCARE |
| Address | 3330 Wilkens Ave, Baltimore, MD 21229 |
| Phone Number | 410-525-1544 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems-potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
› Verified 3 days ago
| NPI Number | 1487600466 |
| Organization Name | CATON MANOR CENTER LLC |
| Doing Business As | CATON MANOR |
| Address | 3330 Wilkens Ave, Baltimore, MD 21229 |
| Phone Number | 410-525-1544 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems-potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
› Verified 3 days ago
| NPI Number | 1881232734 |
| Organization Name | WILKENS AVE BALTIMORE MD OPCO LLC |
| Address | 3330 Wilkens Ave, Baltimore, MD 21229 |
| Phone Number | 410-525-1544 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems-potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems-potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $147979 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.21 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.47 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 45.13 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.14 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.78 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.88 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.31 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.85 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.3 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 66.67 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.33 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 47.99 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.43 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 17.01 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.37 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.12 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 59.28 | 82.93 |
News Archive
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
Forced-air systems used to keep patients warm during surgery may affect the performance of operating room (OR) ventilation systems-potentially increasing exposure to airborne contaminants, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
› Verified 3 days ago
King David Nursing And Rehabilitation Center Location: 4204 Old Milford Mill Road, Baltimore, Maryland 21208 Phone: (410) 486-1500 | |
Autumn Lake Healthcare At Long Green Location: 115 East Melrose Avenue, Baltimore, Maryland 21212 Phone: (410) 435-9073 | |
Levindale Hebrew Ger Ctr & Hsp Location: 2434 W. Belvedere Avenue, Baltimore, Maryland 21215 Phone: (410) 466-8700 | |
Keswick Multi-care Center Location: 700 West 40th Street, Baltimore, Maryland 21211 Phone: (410) 235-8860 | |
St. Elizabeth Rehab. & Nsg. Ce Location: 3320 Benson Avenue, Baltimore, Maryland 21227 Phone: (667) 600-2600 | |
Autumn Lake Healthcare At Homewood Location: 6000 Bellona Avenue, Baltimore, Maryland 21212 Phone: (410) 323-4223 |